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ABSTRACT 
Introduction: Aromatic L-amino acid decarboxylase deficiency (AADC) is a rare autosomal 
recessive pediatric neurotransmitter disease. To date it remains poorly understood mainly due 
to an absence of a disease model. The dopaminergic neuroblastoma cell SH-SY5Y was 
chosen to develop our AADC deficiency model. These cells are not native dopamine 
synthesizers. Objective: To develop a dopamine-producing cellular model of AADC 
deficiency using SH-SY5Y neuroblastoma cells. Methods: Dopamine pathway proteins were 
identified with Western Blotting. Dopaminergic differentiation was attempted using all-trans 
retinoic acid (ATRA) with dopamine detection via HPLC-ECD post alumina extraction. 
Treatment with L-DOPA provided SH-SY5Y with excess precursor. RT-PCR was used to 
determine the expression of markers of mature neurons. Results: Western Blot screening 
identified AADC, dopamine β-hydroxylase and tyrosine hyrdoxylase proteins, indicative of a 
dopaminergic pathway. ATRA was unsuccessful in producing dopamine from the cells. L-
DOPA treatment however, generated dopamine first visible as a HPLC-ECD peak 30 minutes 
post-incubation. Prior to this, SH-SY5Y dopamine synthesis from L-DOPA has never been 
documented. This de novo synthesis is then inhibited using benserazide to form our AADC 
deficiency cell model. RT-PCR showed that SH-SY5Y cells express markers of mature 
neurons in its ‘native’ state and is not affected by L-DOPA and benserazide treatment. This 
cell model will potentially benefit many areas of AADC deficiency research. Conclusion: 
SH-SY5Y cells   produced HPLC-ECD measureable amounts of dopamine with the addition 
of L-DOPA. Our model of AADC deficiency is generated by quelling the dopamine 
production with Benserazide. 
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